EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtVergleichsstudie

Endoluminal radiofrequency ablation with stenting versus stenting alone in patients with malignant biliary obstruction: a meta-analysis of randomized trials

Daryl Ramai, Marcello Maida iD, Eric R Smith, Yichen Wang iD, Marco Spadaccini, Melissa Previtera, Saurabh Chandan iD, Yuting Huang iD, Salih Tokmak iD, Peter Bhandari, Jason DuBroff, Christopher Ko und 6 weitere

Endoscopy · 2025-03 · 57 (03) · 272-281

DOI: 10.1055/a-2378-9533 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Endoscopy, online erschienen am 06.11.2024. Verfasst von Daryl Ramai und 17 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology, University of Utah Health, Salt Lake City, United States. Hauptthemen laut MEDLINE: Stents, Radiofrequency Ablation, Cholestasis, Bile Duct Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endoluminal radiofrequency ablation (RFA) is a palliative treatment for patients suffering from malignant biliary obstruction (MBO). We aimed to conduct a meta-analysis to evaluate the impact of RFA on stent patency, patient survival, and adverse events. Major databases were searched through December 2023 for patients who had undergone stenting with or without RFA for extrahepatic MBO. A random-effects model was used for analysis, with results expressed as relative risk ratios (RRs) with 95%CIs. Nine RCTs involving 750 subjects with MBO (374 RFA plus stent vs. 376 stent only) were included. Meta-analysis revealed similar risks of stent patency at 3 months (RR 1.01, 95%CI 0.92–1.11; I 2 = 4%) for RFA plus stenting vs. stent only. Meta-analysis showed improved survival at 6 months (RR 0.84, 95%CI 0.73–0.96; I 2 = 21%; P = 0.01) for RFA plus stenting vs. stent only. Subgroup analysis comparing plastic vs. uncovered metal stents showed that stent patency was unaffected at 3 months (RR 1.06, 95%CI 0.91–1.23; I 2 = 17%). Subgroup analysis showed that patients with cholangiocarcinoma experienced an overall survival benefit with RFA plus stenting vs. stenting alone (P < 0.001); however, stent patency remained unaffected (P = 0.08). An increased incidence of cholecystitis was noted with RFA plus stenting vs. stenting alone (5.1% [95%CI 3.1%–7.8%] vs. 0.3% [95%CI 0.01%–1.5%], respectively). Combining endoluminal RFA and stenting may improve overall survival in patients with MBO. RFA did not significantly impact stent patency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StentsRadiofrequency AblationCholestasisBile Duct NeoplasmsHumansRandomized Controlled Trials as TopicPalliative CareCombined Modality Therapy

Autor:innen und Institutionen

  • Gastroenterology and Hepatology, University of Utah Health, Salt Lake City, United States.
  • Gastroenterology, S. Elia - Raimondi Hospital, Caltanissetta, Italy.
  • Medicine and Surgery, Kore University of Enna, Enna, Italy.
  • Medicine, Baylor Scott & White Health, Dallas, United States.
  • Hospital Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

ORCID-Profile: Marcello Maida, Yichen Wang, Saurabh Chandan, Yuting Huang, Salih Tokmak, Giovanni Marasco, Stefano Francesco Crinó, Antonio Facciorusso, Benedetto Mangiavillano

Zitieren

APA

Ramai, D., Maida, M., Smith, E. R., Wang, Y., Spadaccini, M., Previtera, M., Chandan, S., Huang, Y., Tokmak, S., Bhandari, P., DuBroff, J., Ko, C., Morris, J. D., Marasco, G., Crinó, S. F., Facciorusso, A., Mangiavillano, B., & Khashab, M. A. (2025). Endoluminal radiofrequency ablation with stenting versus stenting alone in patients with malignant biliary obstruction: a meta-analysis of randomized trials. Endoscopy, 57(03), 272-281. https://doi.org/10.1055/a-2378-9533

Vancouver

Ramai D, Maida M, Smith ER, Wang Y, Spadaccini M, Previtera M, et al. Endoluminal radiofrequency ablation with stenting versus stenting alone in patients with malignant biliary obstruction: a meta-analysis of randomized trials. Endoscopy. 2025;57(03):272-281. doi:10.1055/a-2378-9533

BibTeX
@article{Ramai2025,
  author = {Ramai, Daryl and Maida, Marcello and Smith, Eric R and Wang, Yichen and Spadaccini, Marco and Previtera, Melissa and Chandan, Saurabh and Huang, Yuting and Tokmak, Salih and Bhandari, Peter and DuBroff, Jason and Ko, Christopher and Morris, John D and Marasco, Giovanni and Crinó, Stefano Francesco and Facciorusso, Antonio and Mangiavillano, Benedetto and Khashab, Mouen A},
  title = {Endoluminal radiofrequency ablation with stenting versus stenting alone in patients with malignant biliary obstruction: a meta-analysis of randomized trials},
  journal = {Endoscopy},
  year = {2025},
  volume = {57},
  number = {03},
  pages = {272--281},
  doi = {10.1055/a-2378-9533}
}
Kostenlos starten →